Can Patients at Low Risk of Surgery Have TAVR?

3D Illustration of Human Heart AnatomyThe PARTNER-3 Continued Access Trial: TAVR in low-risk patients

Brigham and Women’s Hospital is one of two centers in New England currently participating in the PARTNER 3 Continued Access Trial that offers transcatheter aortic valve replacement (TAVR) to low-risk patients undergoing valve replacement for severe aortic stenosis.
Read More

Post-Operative Tracking Saves Lives at the Aortic Disease Center

Echocardiogram to patient in hospitalAll patients who undergo a cardiac procedure at the Aortic Disease Center are placed on a list. After discharge, these patients are systematically followed via a robust post-operative tracking system. Issues that crop up are spotted fast.
Read More

VT Ablation with Investigational Needle Catheter Shows Promise in Patients

catheter ablation computer renderingCatheter ablation has become an important therapy for patients with ventricular tachycardia (VT). However, it has been a challenge to access arrhythmia sources deep within the heart muscle with the use of conventional approaches.
Read More

Brigham’s TAVR Program Achieves High Volume with Speed and Efficiency

It’s estimated that approximately 168,000 TAVR procedures will be performed annually in the United States. According to Pinak Bipin Shah, MD, most TAVR programs grew quickly after the FDA decreased the risk-level indication, but many programs have plateaued.

Read More

A Heart-Lung Transplantation Marks a New Era – for Patient and Hospital

3D Illustration of Human Body Organs (Lungs with Heart Anatomy)Building on pioneering work performed during the first wave of heart-lung transplantation, Brigham and Women’s Hospital has resumed its heart-lung program and is once again performing the rare procedure.

Read More

Brigham Investigators Present Cardiovascular Discoveries at AHA Conference

Heart attack and chest pain medical cardiovascular disease as an illness of a human circulation organ in a 3D illustration style.On November 10, 2018, the American Heart Association (AHA) held its annual Scientific Sessions meeting, featuring the latest advances from major cardiovascular trials with the potential to transform clinical practice. Investigators from the Brigham led some of the most highly anticipated trials and presented their results at the conference.
Read More

FDA-Approved HeartMate 3 Pump Provides New Option for Advanced Heart Failure Patients

On October 19th, 2018, the HeartMate 3 Left Ventricular Assist System (LVAD) was approved by the FDA as a destination therapy for patients with advanced heart failure who are not eligible for a heart transplant.

Read More

1000th TAVR Performed at Brigham and Women’s Hospital

In April 2018, the Brigham and Women’s Hospital (BWH) Heart & Vascular Center became the first in New England to perform their 1,000th transcatheter aortic valve replacement (TAVR) procedure.

Read More

Cutting-Edge Imaging in the Hybrid Operating Room

The hybrid operating room at the Brigham and Women’s Hospital Heart & Vascular Center now features the state-of-art ARTIS Pheno angiography system. As of March 2018, patients who require hybrid cardiovascular interventions combining intravascular and open surgical procedures are reaping the rewards of this cutting-edge technology.

Read More

Advancing Minimally Invasive and Transcatheter Valve Therapies

The history of surgery for valvular heart disease at Brigham and Women’s Hospital (BWH) dates to May 1923 when Elliott Carr Cutler, MD, performed the first ever valve operation in the world. Since then, BWH has been at the forefront of the clinical practice and innovation in the management of valve disease. Read More